Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026)
Nexalin Technology (NXL) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.99 Bn | 194.39 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 129.76 Bn | 126.29 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 120.27 Bn | 111.05 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.98 Bn | 73.44 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 52.67 Bn | 48.42 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.50 Bn | 23.18 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.22 Bn | 22.74 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Nexalin Technology | 7.11 Mn | 6.11 Mn | 8,897.00 | 852,838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 852,838.00 |
| Mar 31, 2026 | 792,797.00 |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 779,900.00 |
| Jun 30, 2025 | 687,012.00 |
| Mar 31, 2025 | 929,220.00 |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 598,757.00 |
| Mar 31, 2024 | 483,313.00 |
| Dec 31, 2023 | -872,610.00 |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 479,545.00 |
| Mar 31, 2023 | 344,953.00 |
| Dec 31, 2022 | 407,930.00 |
| Sep 30, 2022 | 479,445.00 |
| Jun 30, 2022 | 385,990.00 |
| Mar 31, 2022 | 218,374.00 |
| Dec 31, 2021 | 296,093.00 |
| Sep 30, 2021 | 1.62 Mn |